Leukaemic meningo-encephalopathy: treatment with intrathecal methotrexate.
作者信息
Misra R C, Basu A K
出版信息
J Assoc Physicians India. 1973 Oct;21(10):895-903.
PMID:4802076
Abstract
摘要
相似文献
1
Leukaemic meningo-encephalopathy: treatment with intrathecal methotrexate.白血病性脑膜脑病：鞘内注射甲氨蝶呤治疗
J Assoc Physicians India. 1973 Oct;21(10):895-903.
2
Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia.脑膜白血病中的神经毒性和脑脊液甲氨蝶呤浓度升高
N Engl J Med. 1973 Oct 11;289(15):770-3. doi: 10.1056/NEJM197310112891503.
3
Submicroscopic changes in leukaemia cells of the cerebrospinal fluid following intrathecal methotrexate.鞘内注射甲氨蝶呤后脑脊液中白血病细胞的亚显微变化。
Acta Neuropathol. 1974;29(4):345-54. doi: 10.1007/BF00685487.
4
[Prophylaxis and treatment of adult central nervous system leukemia].
Rinsho Ketsueki. 1988 Apr;29(4):462-6.
5
Treatment of meningeal neoplasms.脑膜肿瘤的治疗。
Cancer Treat Rep. 1977 Jul;61(4):733-43.
6
[Successful intrathecal treatment of meningeal leukaemia with methotrexate in the adult].[甲氨蝶呤成功鞘内治疗成人脑膜白血病]
Dtsch Med Wochenschr. 1973 Feb 9;98(6):259-61. doi: 10.1055/s-0028-1106790.
7
8
Superiority of conventional intrathecal methotrexate therapy with maintenance over intensive intrathecal methotrexate therapy, unmaintained, or radiotherapy (2000-2500 rads tumor dose) in treatment for meningeal leukemia.在治疗脑膜白血病方面，常规鞘内注射甲氨蝶呤维持治疗优于未维持的强化鞘内注射甲氨蝶呤治疗或放射治疗（肿瘤剂量2000 - 2500拉德）。
Cancer. 1975 Apr;35(4):1066-73. doi: 10.1002/1097-0142(197504)35:4<1066::aid-cncr2820350408>3.0.co;2-r.
9
[Neuroleukemias. Treatment of meningeal leukemia].[神经白血病。脑膜白血病的治疗]
Hospital (Rio J). 1970 Nov-Dec;78(5):1397-405.
10
Encephalopathy in acute leukaemia associated with methotrexate therapy.
Arch Dis Child. 1972 Jun;47(253):344-54. doi: 10.1136/adc.47.253.344.
Zotero 插件